Stress Reactivity Among African American Breast Cancer Survivors
Completed
Conditions studied: Breast Cancer Female, Stress Reaction
In brief
Despite increased access to early detection and the availability of more effective therapeutic strategies, African American women continue to experience excess rates of morbidity and mortality from breast cancer. An emerging hypothesis about breast cancer disparities is that social conditions and physiological responses to social stressors influence biological processes that are important to the initiation and progression of disease. This hypothesis is based on data from animal studies which have shown that rats that are exposed to social stressors such as isolation are likely to develop mammary tumors that are histologically and etiologically similar to those that develop among African American women. The HPA axis plays a central role in regulating the physiological stress response; dysregulation of the HPA has been suggested as a mechanism through which social and biological factors contribute to racial disparities in breast cancer outcomes. Many African Americans experience stressful life events and circumstances, including economic, discriminatory, and other stressors. These social factors may contribute to an increased risk of advanced stage disease, but not all African American women who are exposed to adverse social factors develop advanced stage disease and those who have a limited number of psychosocial stressors can develop advanced stage breast cancer, regardless of early detection. This may be because stress reactivity, or one's physiological and psychological responses to a stressor, is highly individualized and dependent on psychological and social determinants as well as genetic factors. But, these biological and psychosocial pathways have not been examined among women at increased risk for disparities. Therefore, this study will characterize stress reactivity and emotional regulation among African American breast cancer survivors and measure the association between these responses and decisions about cancer control and treatment compliance. As part of providing empirical data on biological and psychological pathways that contribute to breast cancer disparities, the investigator's study will identify novel intervention targets that can be used to improve self-management in a population that is at risk for limited cancer control.
Key facts
- Study ID
- NCT03881085
- Run by
- Medical University of South Carolina
- People needed
- 110
- Starts
- 2018-10-19
- Expected to finish
- 2021-07-20
- Last updated by the study team
- 2026-02-02
Who can join
Age: 21 and older, up to 75. Sex: female. Healthy volunteers: not accepted.
You may qualify if…
- Self-identify as African American or Black women
- Histologically confirmed stage of I, II, or IIIa breast cancer.
- Between the ages of 21-75 at diagnosis
- Have been diagnosed within the last 5 years
You may not qualify if…
- Women who are not African American or Black
- Diagnosed with a later stage of breast cancer
- Not within the defined treatment parameters
Where it is running
- Medical University of South Carolina — Charleston, South Carolina, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.